Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Clinical trial NCT03172455 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT03172455
Sponsor: Impatients N.V. trading as myTomorrows
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Acute-graft-versus-host Disease Steroid Refractory Acute Graft Versus Host Disease Graft-versus-host-disease Graft Vs Host Disease Alpha 1-Antitrypsin Deficiency Alpha-1 Proteinase Inhibitor Alpha-1 Protease Inhibitor Deficiency Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.